| Mrs Cara Anne Martinez, NP-C | |
|
444 N Eola Rd Ste 110, Aurora, IL 60502-9619 | |
| (630) 692-5660 | |
| (630) 692-5661 |
| Full Name | Mrs Cara Anne Martinez |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 444 N Eola Rd Ste 110, Aurora, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346722535 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 041378363 (Illinois) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 209018118 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Edward Hospital | Naperville, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Edward Hospital | 0042108110 | 98 |
| Edward Health Ventures | 4284531484 | 510 |
News Archive
Oxygen Biotherapeutics, Inc. today announced that the first patient has been enrolled in the company's Phase II-b, dose escalation, clinical trial in Switzerland for use of Oxycyte(TM) emulsion in traumatic brain injury (TBI). Oxycyte is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier.
An Indiana University cancer researcher and her colleagues have identified genetic markers that may help determine who benefits from regular use of aspirin and other nonsteroidal anti-inflammatory drugs for lowering one's risk of developing colorectal cancer.
Fox Chase Cancer Center researchers have presented preliminary results of a clinical trial in which women received a two-week shorter course of radiation therapy than the current standard following a lumpectomy.
On Tuesday, March 9, 2010 at 3:30 pm, The W. Garfield Weston Foundation will present The Salvation Army Homestead (78 Admiral Rd, Toronto) a residential recovery program for women struggling with substance abuse, with a donation of $1.5 million for urgently needed building renovations.
› Verified 1 days ago
| Entity Name | Edward Health Ventures |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962452912 PECOS PAC ID: 4284531484 Enrollment ID: O20031216000616 |
News Archive
Oxygen Biotherapeutics, Inc. today announced that the first patient has been enrolled in the company's Phase II-b, dose escalation, clinical trial in Switzerland for use of Oxycyte(TM) emulsion in traumatic brain injury (TBI). Oxycyte is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier.
An Indiana University cancer researcher and her colleagues have identified genetic markers that may help determine who benefits from regular use of aspirin and other nonsteroidal anti-inflammatory drugs for lowering one's risk of developing colorectal cancer.
Fox Chase Cancer Center researchers have presented preliminary results of a clinical trial in which women received a two-week shorter course of radiation therapy than the current standard following a lumpectomy.
On Tuesday, March 9, 2010 at 3:30 pm, The W. Garfield Weston Foundation will present The Salvation Army Homestead (78 Admiral Rd, Toronto) a residential recovery program for women struggling with substance abuse, with a donation of $1.5 million for urgently needed building renovations.
› Verified 1 days ago
| Entity Name | Edward Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013969013 PECOS PAC ID: 0042108110 Enrollment ID: O20040309001279 |
News Archive
Oxygen Biotherapeutics, Inc. today announced that the first patient has been enrolled in the company's Phase II-b, dose escalation, clinical trial in Switzerland for use of Oxycyte(TM) emulsion in traumatic brain injury (TBI). Oxycyte is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier.
An Indiana University cancer researcher and her colleagues have identified genetic markers that may help determine who benefits from regular use of aspirin and other nonsteroidal anti-inflammatory drugs for lowering one's risk of developing colorectal cancer.
Fox Chase Cancer Center researchers have presented preliminary results of a clinical trial in which women received a two-week shorter course of radiation therapy than the current standard following a lumpectomy.
On Tuesday, March 9, 2010 at 3:30 pm, The W. Garfield Weston Foundation will present The Salvation Army Homestead (78 Admiral Rd, Toronto) a residential recovery program for women struggling with substance abuse, with a donation of $1.5 million for urgently needed building renovations.
› Verified 1 days ago
| Entity Name | Rush-copley Medical Group Nfp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093075848 PECOS PAC ID: 7618864877 Enrollment ID: O20040310001029 |
News Archive
Oxygen Biotherapeutics, Inc. today announced that the first patient has been enrolled in the company's Phase II-b, dose escalation, clinical trial in Switzerland for use of Oxycyte(TM) emulsion in traumatic brain injury (TBI). Oxycyte is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier.
An Indiana University cancer researcher and her colleagues have identified genetic markers that may help determine who benefits from regular use of aspirin and other nonsteroidal anti-inflammatory drugs for lowering one's risk of developing colorectal cancer.
Fox Chase Cancer Center researchers have presented preliminary results of a clinical trial in which women received a two-week shorter course of radiation therapy than the current standard following a lumpectomy.
On Tuesday, March 9, 2010 at 3:30 pm, The W. Garfield Weston Foundation will present The Salvation Army Homestead (78 Admiral Rd, Toronto) a residential recovery program for women struggling with substance abuse, with a donation of $1.5 million for urgently needed building renovations.
› Verified 1 days ago
| Entity Name | Northshore University Healthsystem Faculty Practice Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497701882 PECOS PAC ID: 2163334699 Enrollment ID: O20040524000118 |
News Archive
Oxygen Biotherapeutics, Inc. today announced that the first patient has been enrolled in the company's Phase II-b, dose escalation, clinical trial in Switzerland for use of Oxycyte(TM) emulsion in traumatic brain injury (TBI). Oxycyte is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier.
An Indiana University cancer researcher and her colleagues have identified genetic markers that may help determine who benefits from regular use of aspirin and other nonsteroidal anti-inflammatory drugs for lowering one's risk of developing colorectal cancer.
Fox Chase Cancer Center researchers have presented preliminary results of a clinical trial in which women received a two-week shorter course of radiation therapy than the current standard following a lumpectomy.
On Tuesday, March 9, 2010 at 3:30 pm, The W. Garfield Weston Foundation will present The Salvation Army Homestead (78 Admiral Rd, Toronto) a residential recovery program for women struggling with substance abuse, with a donation of $1.5 million for urgently needed building renovations.
› Verified 1 days ago
| Entity Name | Aurora Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407379423 PECOS PAC ID: 1850657180 Enrollment ID: O20171102000998 |
News Archive
Oxygen Biotherapeutics, Inc. today announced that the first patient has been enrolled in the company's Phase II-b, dose escalation, clinical trial in Switzerland for use of Oxycyte(TM) emulsion in traumatic brain injury (TBI). Oxycyte is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier.
An Indiana University cancer researcher and her colleagues have identified genetic markers that may help determine who benefits from regular use of aspirin and other nonsteroidal anti-inflammatory drugs for lowering one's risk of developing colorectal cancer.
Fox Chase Cancer Center researchers have presented preliminary results of a clinical trial in which women received a two-week shorter course of radiation therapy than the current standard following a lumpectomy.
On Tuesday, March 9, 2010 at 3:30 pm, The W. Garfield Weston Foundation will present The Salvation Army Homestead (78 Admiral Rd, Toronto) a residential recovery program for women struggling with substance abuse, with a donation of $1.5 million for urgently needed building renovations.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Cara Anne Martinez, NP-C 444 N Eola Rd Ste 110, Aurora, IL 60502-9619 Ph: (630) 692-5660 | Mrs Cara Anne Martinez, NP-C 444 N Eola Rd Ste 110, Aurora, IL 60502-9619 Ph: (630) 692-5660 |
News Archive
Oxygen Biotherapeutics, Inc. today announced that the first patient has been enrolled in the company's Phase II-b, dose escalation, clinical trial in Switzerland for use of Oxycyte(TM) emulsion in traumatic brain injury (TBI). Oxycyte is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier.
An Indiana University cancer researcher and her colleagues have identified genetic markers that may help determine who benefits from regular use of aspirin and other nonsteroidal anti-inflammatory drugs for lowering one's risk of developing colorectal cancer.
Fox Chase Cancer Center researchers have presented preliminary results of a clinical trial in which women received a two-week shorter course of radiation therapy than the current standard following a lumpectomy.
On Tuesday, March 9, 2010 at 3:30 pm, The W. Garfield Weston Foundation will present The Salvation Army Homestead (78 Admiral Rd, Toronto) a residential recovery program for women struggling with substance abuse, with a donation of $1.5 million for urgently needed building renovations.
› Verified 1 days ago
Courtney Harley, ANP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2720 E New York St, Ste 108, Aurora, IL 60502 Phone: 630-820-7045 Fax: 630-820-7047 | |
Tochi Okwueze, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 400 N Highland Ave, Aurora, IL 60506 Phone: 630-978-2532 | |
Heidijo Elyea, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1256 Waterford Drive, Suite 120, Aurora, IL 60504 Phone: 630-499-6688 Fax: 630-499-6689 | |
Mrs. Haley S.v. Murphy, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 400 N Highland Ave, Aurora, IL 60506 Phone: 630-892-4355 | |
Ms. Carole Wolfson, APN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 581 Sullivan Rd Ste B, Aurora, IL 60506 Phone: 630-859-3877 Fax: 630-859-8920 | |
Ms. Kenisha Francisco, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 400 N Highland Ave, Aurora, IL 60506 Phone: 630-978-2532 | |
Terra L Kolacki, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 444 N Eola Rd Ste 110, Aurora, IL 60502 Phone: 630-692-5660 Fax: 630-692-5661 |